Healthcare provider profile · identity verified

Devi Dunker, D.O.

Family Practice · BOONE, IA · NPI 1881959971

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	459	117
Levothyroxine Sodium	Levothyroxine Sodium	438	98
Amlodipine Besylate	Amlodipine Besylate	327	79
Lisinopril	Lisinopril	314	76
Omeprazole	Omeprazole	246	55
Losartan Potassium	Losartan Potassium	226	54
Metoprolol Succinate	Metoprolol Succinate	189	45
Simvastatin	Simvastatin	183	40
Potassium Chloride	Potassium Chloride	167	37
Rosuvastatin Calcium	Rosuvastatin Calcium	166	43
Furosemide	Furosemide	165	36
Gabapentin	Gabapentin	155	38
Sertraline Hcl	Sertraline Hcl	135	35
Pantoprazole Sodium	Pantoprazole Sodium	130	33
Tramadol Hcl	Tramadol Hcl	124	40
Eliquis	Apixaban	114	25
Metformin Hcl	Metformin Hcl	114	32
Hydrochlorothiazide	Hydrochlorothiazide	112	33
Clopidogrel	Clopidogrel Bisulfate	88	19
Ozempic	Semaglutide	87	18
Albuterol Sulfate Hfa	Albuterol Sulfate	86	41
Donepezil Hcl	Donepezil Hcl	84	14
Venlafaxine Hcl Er	Venlafaxine Hcl	84	12
Pravastatin Sodium	Pravastatin Sodium	79	21
Warfarin Sodium	Warfarin Sodium	79	11
Citalopram Hbr	Citalopram Hydrobromide	77	21
Fluoxetine Hcl	Fluoxetine Hcl	77	19
Montelukast Sodium	Montelukast Sodium	76	16
Spironolactone	Spironolactone	72	17
Metformin Hcl Er	Metformin Hcl	71	18
Alprazolam	Alprazolam	65	13
Metoprolol Tartrate	Metoprolol Tartrate	65	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	63	12
Trazodone Hcl	Trazodone Hcl	61	17
Clonazepam	Clonazepam	60	suppressed
Prednisone	Prednisone	60	37
Duloxetine Hcl	Duloxetine Hcl	58	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	15
Meloxicam	Meloxicam	55	17
Atenolol	Atenolol	54	suppressed
Bupropion Xl	Bupropion Hcl	51	17
Chlorthalidone	Chlorthalidone	51	13
Alendronate Sodium	Alendronate Sodium	50	17
Escitalopram Oxalate	Escitalopram Oxalate	50	13
Famotidine	Famotidine	49	11
Memantine Hcl	Memantine Hcl	49	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	49	suppressed
Paroxetine Hcl	Paroxetine Hcl	48	11
Pregabalin	Pregabalin	47	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	13
Jardiance	Empagliflozin	40	11
Celecoxib	Celecoxib	39	suppressed
Diclofenac Sodium	Diclofenac Sodium	38	17
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	38	24
Allopurinol	Allopurinol	37	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	suppressed
Baclofen	Baclofen	36	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	14
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	32	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	31	11
Aripiprazole	Aripiprazole	30	suppressed
Gemtesa	Vibegron	30	suppressed
Metolazone	Metolazone	30	suppressed
Nystatin	Nystatin	30	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	15
Lorazepam	Lorazepam	29	suppressed
Trulicity	Dulaglutide	28	suppressed
Glimepiride	Glimepiride	27	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	27	suppressed
Valacyclovir	Valacyclovir Hcl	26	suppressed
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Cephalexin	Cephalexin	23	19
Valsartan	Valsartan	23	suppressed
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Temazepam	Temazepam	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	13
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Bumetanide	Bumetanide	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	17	suppressed
Fluconazole	Fluconazole	17	11
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Naproxen	Naproxen	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Risperidone	Risperidone	17	suppressed
Diazepam	Diazepam	15	suppressed
Glyxambi	Empagliflozin/Linagliptin	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	13
Janumet Xr	Sitagliptin Phos/Metformin Hcl	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Azithromycin	Azithromycin	13	12
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Dilt-Xr	Diltiazem Hcl	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Linzess	Linaclotide	13	suppressed
Ramipril	Ramipril	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Amoxicillin	Amoxicillin	11	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error